Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Alvin Schmaier, MD

Alvin Schmaier, MD

  • Director, Seidman Cancer Center Lab, UH Cleveland Medical Center
  • Director, Adult Hemophilia Program, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine
  • Robert W. Kellermeyer, MD, Chair in Oncology, UH Seidman Cancer Center
  • Specialty: Hematology and Oncology
  • Location:
    UH Seidman Cancer Center
    11100 Euclid Ave
    Cleveland, OH 44106

Biography: Alvin Schmaier, MD

Expertise

  • Anticoagulant Management
  • Classical Hematology
  • Hemostasis and Thrombosis
  • Hereditary Angioedema
  • Porphyria
  • Thrombotic Microangiopathies

Certifications & Memberships

  • Medical Oncology - American Board of Internal Medicine
  • Hematology - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine

Education

Research Fellowship | Hematology/Oncology
Hematology/Oncology - Temple University Hospital (1979 - 1980)

Fellowship | Hematology/Oncology
Hematology/Oncology - Hospital Of The University Of Pennsylvania (1977 - 1979)

Residency | Internal Medicine
Internal Medicine - Temple University Hospital (1975 - 1977)

Internship | Internal Medicine
Internal Medicine - Temple University (1974 - 1975)

Medical Education
Virginia Commonwealth University School Of Medicine (1974)

Undergraduate
University Of Virginia (1970)

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Alvin Schmaier disclosed the following Outside Relationships with Industry:

  • - Lippincott Publishers - Intellectual Property